Dexmedetomidine nasal drops combined with sevoflurane inhalation in application of lacrimal duct probing in children

Application of dexmedetomidine nasal drop combined with sevoflurane non-intubated general anesthesia for lacrimal duct probing in infants

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200061025

Enrollment

Unknown

Registered

2022-06-15

Start date

2022-06-01

Completion date

Unknown

Last updated

2023-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anaesthesia program for lacrimal duct probing in children

Interventions

control group:General anesthesia with sevoflurane alone

Experimental group:Dexmedetomidine nasal drops combined with sevoflurane anesthesia

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. aged 6-12m; 2. BIM 20-26 kg/m2; 3. No gender limitation; 4. ASA grade I or II; 5. Single tear duct probing was performed.

Exclusion criteria

Exclusion criteria: 1.Premature infants, cognitive impairment, cardiopulmonary dysfunction, developmental delay and mental retardation; 2. Recent severe upper respiratory tract infection and other diseases; 3. A history of anesthesia; 4. There were other serious cardiovascular complications before surgery.

Design outcomes

Primary

Measure	Time frame
Watcha scale;	—

Countries

China

Contacts

Public ContactWanna Jiang

Wenzhou Medical University Affiliated Optometry Hospital

jiangwanna1314@sina.com+86 13758475106

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026